We first investigated whether the FMD was able to intervene in the progression of type 2 diabetes in db/db mice that are susceptible to the development of severe diabetes due to morbid obesity caused by a lack of leptin receptors. The gene discussed is LEPR; the disease is type 2 diabetes mellitus.